Published : 12/16/2019  -  Categories : News

Alsachim has developed all the protein kinase standards approved by the FDA, you can now get access to these standards to boost your research.

Protein Kinase inhibitors have always been at the core of cancer research. They enable targeted therapy aimed against cancer-specific molecules and signaling pathways with utterly limited non specific toxicities.

The Food and Drug Administration has recently approved a list of small molecule protein kinase inhibitors for their anticancer properties. You can now order the reference and labeled standards for all the protein kinase ever approved by the FDA. 

CLICK HERE TO DOWNLOAD THE PROTEIN KINASE INHIBITORS PRODUCT SHEET

Contact us now to get more information and a personalized quote for these products.

Search on news